Cardiff Oncology Inc. (CRDF)
NASDAQ · Healthcare
Cardiff Oncology Inc. Operating Income 2011–2025
Cardiff Oncology Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cardiff Oncology Inc. operating income for the quarter ending March 31, 2026 was -12.8 M, a 10.65% decrease year-over-year.
- Cardiff Oncology Inc. operating income for the twelve months ending March 31, 2026 was -54.0 M, a 15.10% increase year-over-year.
- Cardiff Oncology Inc. annual operating income for 2025 was -49.0 M, a 0.64% increase from 2024.
- Cardiff Oncology Inc. annual operating income for 2024 was -48.7 M, a 7.13% increase from 2023.
- Cardiff Oncology Inc. annual operating income for 2023 was -45.4 M, a 13.81% increase from 2022.
- Cardiff Oncology Inc. annual operating income for 2022 was -39.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cardiff Oncology Inc. Operating Income — FAQ
Cardiff Oncology Inc. (CRDF) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Cardiff Oncology Inc.'s operating income?
Cardiff Oncology Inc. (CRDF) reported operating income of -$49M for fiscal 2025.
Where can I see CRDF's operating income history?
The chart and table above show Cardiff Oncology Inc.'s operating income by year and by quarter, including the growth rate.